peoplePerson
Caroline Dive
Built small-cell lung cancer models from circulating tumour cells and leads the Manchester institute.
Caroline Dive pioneered CTC-derived explant models of small-cell lung cancer and leads Manchester's Cancer Research UK institute and its biomarker centre.
Role
Director, Cancer Research UK Manchester Institute; Professor of Cancer Pharmacology
Institution
Specialisms
Liquid biopsyCirculating tumour cellsSmall-cell lung cancer models
Profiles
| Title | Journal | Year |
|---|---|---|
| Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer | Nature Medicine | 2014 |
Pages like this
not linked directly; found by shared links- PersonFiona Blackhall
Shares Grow blood-borne tumour cells to test drugs on the cells that actually spread, Cancer Research UK Manchester Institute, The Christie NHS Foundation Trust, Small-cell lung cancer.
- IdeaGrow models from tumour cells in the blood when a biopsy is impossible
Shares Patient-derived xenografts, Small-cell lung cancer, Liquid biopsy (ctDNA).
- IdeaMulti-centre randomised animal trials before committing to a human trial
- PersonKlaus Pantel
Shares Circulating tumour cell clearance as the phase 2 gate for anti-metastatic drugs, Liquid biopsy (ctDNA).
- InstitutionBeatson West of Scotland Cancer Centre / CRUK Scotland Institute
- IdeaDetect tumours changing cell type from RNA in the blood
- IdeaAttack extrachromosomal DNA, the engine of oncogene amplification
Shares Cancer Research UK, Liquid biopsy (ctDNA).
- InstitutionIstituto di Candiolo IRCCS – FPO